Smith+Nephew Says Talks With J&J Have Ended and Cuts 2026 Outlook as US Hip and Knee Sales Weaken
What the end of Smith+Nephew’s J&J talks means for MedTech mergers and acquisitions: a second guidance cut, an Orthopaedics review and many open questions.